Stock DRREDDY DR. REDDY'S LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Dr. Reddy's Laboratories Limited NSE India S.E.

Equities

DRREDDY

INE089A01023

Market Closed - NSE India S.E.
Other stock markets
 07:40:47 2024-05-23 am EDT 		5-day change 1st Jan Change
5,898 INR +0.42% Intraday chart for Dr. Reddy's Laboratories Limited +0.39% +1.72%
May. 22 Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading MT
May. 22 Indian shares set to rise at open; Fed minutes eyed RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading
MT
Indian shares set to rise at open; Fed minutes eyed
RE
Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
MT
Alvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK
BU
Alvotech and Dr. Reddy's Partner to Commercialize Biosimilar Candidate Denosumab
MT
Asian Equities Traded in the US as American Depositary Receipts Open Week Higher
MT
Asian Equities Traded in the US as American Depositary Receipts Ease in Thursday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Begin Week Higher
MT
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week 1% Lower
MT
Asian Equities Traded in the US as American Depositary Receipts Trend Lower Thursday
MT
India's Alembic Pharma posts higher Q4 profit on strong N.America sales
RE
Asian Equities Traded in the US as American Depositary Receipts Trend Slightly Lower in Wednesday Trading
MT
Indian Equities Settle Flat on Wednesday, Dragged by Banks, FMCG Stocks
MT
Jefferies Adjusts Dr. Reddy’s Laboratories’ Price Target to INR5,010 From INR5,040, Keeps at Underperform
MT
Dr. Reddy's Consolidated Net Profit Jumps in Fiscal Q4; Shares Slide 3%
MT
Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Tuesday Trading
MT
Dr. Reddy’s Q4 & Full Year FY24 Financial Results
BU
Transcript : Dr. Reddy's Laboratories Limited, Q4 2024 Earnings Call, May 07, 2024
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DRREDDY Stock
  4. DRREDDY Stock
  5. News Dr. Reddy's Laboratories Limited